lobbying_filings_raw: d15da7c4-ebb3-4d4c-abbe-e4dca3a47a82
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| d15da7c4-ebb3-4d4c-abbe-e4dca3a47a82 | Q1 | 61458 | THE RABEN GROUP | 161678 | BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) | 2021 | first_quarter | 2021-04-19T19:29:05.473000-04:00 | 10000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/d15da7c4-ebb3-4d4c-abbe-e4dca3a47a82/", "filing_uuid": "d15da7c4-ebb3-4d4c-abbe-e4dca3a47a82", "filing_type": "Q1", "filing_type_display": "1st Quarter - Report", "filing_year": 2021, "filing_period": "first_quarter", "filing_period_display": "1st Quarter (Jan 1 - Mar 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/d15da7c4-ebb3-4d4c-abbe-e4dca3a47a82/print/", "filing_document_content_type": "text/html", "income": "10000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Robert Raben", "dt_posted": "2021-04-19T19:29:05.473000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "1341 G street NW Flr 5", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "WASHINGTON", "registrant_state": "DC", "registrant_zip": "20005", "registrant": {"id": 61458, "url": "https://lda.senate.gov/api/v1/registrants/61458/", "house_registrant_id": 35394, "name": "THE RABEN GROUP", "description": "National public affairs and strategic communications firm", "address_1": "525 9th Street NW", "address_2": "7th Floor", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20004", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "ROBERT RABEN", "contact_telephone": "+1 202-466-8585", "dt_updated": "2026-01-27T13:56:41.710646-05:00"}, "client": {"id": 161678, "url": "https://lda.senate.gov/api/v1/clients/161678/", "client_id": 1406, "name": "BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND)", "general_description": "Orgaization that promotes women's health", "client_government_entity": false, "client_self_select": false, "state": "CA", "state_display": "California", "country": "US", "country_display": "United States of America", "ppb_state": null, "ppb_state_display": null, "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2008-02-04"}, "lobbying_activities": [{"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Proposals to reform FDA authority and personal care products regulatory system. Legislation that would strengthen supply chain transparency and safety of raw ingredients in cosmetics; ban toxic ingredients linked to harmful impacts on health; full fragrance and flavor ingredient disclosure; and health protections, including a ban on chemicals of concern in products marketed to women of color. Specific bills include the Safe Cosmetics and Personal Care Products Act, Personal Care Products Safety Act; Cosmetic Safety Enhancement Act; and the Natural Cosmetics Act.\n\nFunding for Centers for Disease and Control Biomonitoring program and National Health Tracking Network in FY 22 Labor-HHS-Education bill.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 31195, "prefix": null, "prefix_display": null, "first_name": "KATHARINE", "nickname": null, "middle_name": null, "last_name": "HUFFMAN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 66979, "prefix": null, "prefix_display": null, "first_name": "ABIGAIL", "nickname": null, "middle_name": null, "last_name": "OMOJOLA", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 68970, "prefix": null, "prefix_display": null, "first_name": "DIEGO", "nickname": null, "middle_name": null, "last_name": "SANCHEZ", "suffix": null, "suffix_display": null}, "covered_position": "Legislative Intern, Office of Representative Mike Coffman (CO-06)", "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "ENV", "general_issue_code_display": "Environment/Superfund", "description": "Proposals to reform FDA authority and personal care products regulatory system. Legislation that would strengthen supply chain transparency and safety of raw ingredients in cosmetics; ban toxic ingredients linked to harmful impacts on health; full fragrance and flavor ingredient disclosure; and health protections, including a ban on chemicals of concern in products marketed to women of color. Specific bills include the Safe Cosmetics and Personal Care Products Act, Personal Care Products Safety Act; Cosmetic Safety Enhancement Act; and the Natural Cosmetics Act.\n\nFunding for Centers for Disease and Control Biomonitoring program and National Health Tracking Network in FY 22 Labor-HHS-Education bill.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 31195, "prefix": null, "prefix_display": null, "first_name": "KATHARINE", "nickname": null, "middle_name": null, "last_name": "HUFFMAN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 66979, "prefix": null, "prefix_display": null, "first_name": "ABIGAIL", "nickname": null, "middle_name": null, "last_name": "OMOJOLA", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 68970, "prefix": null, "prefix_display": null, "first_name": "DIEGO", "nickname": null, "middle_name": null, "last_name": "SANCHEZ", "suffix": null, "suffix_display": null}, "covered_position": "Legislative Intern, Office of Representative Mike Coffman (CO-06)", "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "CHM", "general_issue_code_display": "Chemicals/Chemical Industry", "description": "Proposals to reform FDA authority and personal care products regulatory system. Legislation that would strengthen supply chain transparency and safety of raw ingredients in cosmetics; ban toxic ingredients linked to harmful impacts on health; full fragrance and flavor ingredient disclosure; and health protections, including a ban on chemicals of concern in products marketed to women of color. Specific bills include the Safe Cosmetics and Personal Care Products Act, Personal Care Products Safety Act; Cosmetic Safety Enhancement Act; and the Natural Cosmetics Act.\n\nFunding for Centers for Disease and Control Biomonitoring program and National Health Tracking Network in FY 22 Labor-HHS-Education bill.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 31195, "prefix": null, "prefix_display": null, "first_name": "KATHARINE", "nickname": null, "middle_name": null, "last_name": "HUFFMAN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 68970, "prefix": null, "prefix_display": null, "first_name": "DIEGO", "nickname": null, "middle_name": null, "last_name": "SANCHEZ", "suffix": null, "suffix_display": null}, "covered_position": "Legislative Intern, Office of Representative Mike Coffman (CO-06)", "new": false}, {"lobbyist": {"id": 66979, "prefix": null, "prefix_display": null, "first_name": "ABIGAIL", "nickname": null, "middle_name": null, "last_name": "OMOJOLA", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "CSP", "general_issue_code_display": "Consumer Issues/Safety/Products", "description": "Proposals to reform FDA authority and personal care products regulatory system. Legislation that would strengthen supply chain transparency and safety of raw ingredients in cosmetics; ban toxic ingredients linked to harmful impacts on health; full fragrance and flavor ingredient disclosure; and health protections, including a ban on chemicals of concern in products marketed to women of color. Specific bills include the Safe Cosmetics and Personal Care Products Act, Personal Care Products Safety Act; Cosmetic Safety Enhancement Act; and the Natural Cosmetics Act.\n\nFunding for Centers for Disease and Control Biomonitoring program and National Health Tracking Network in FY 22 Labor-HHS-Education bill.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 31195, "prefix": null, "prefix_display": null, "first_name": "KATHARINE", "nickname": null, "middle_name": null, "last_name": "HUFFMAN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 68970, "prefix": null, "prefix_display": null, "first_name": "DIEGO", "nickname": null, "middle_name": null, "last_name": "SANCHEZ", "suffix": null, "suffix_display": null}, "covered_position": "Legislative Intern, Office of Representative Mike Coffman (CO-06)", "new": false}, {"lobbyist": {"id": 66979, "prefix": null, "prefix_display": null, "first_name": "ABIGAIL", "nickname": null, "middle_name": null, "last_name": "OMOJOLA", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |